This company has been marked as potentially delisted and may not be actively trading. CAMP4 Therapeutics (CAMP) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CAMP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period CAMP4 Therapeutics Reports Q2 2025 Progress and OutlookAugust 27 at 12:31 AM | tipranks.comCamp4 Therapeutics reports Q2 EPS (62c), consensus (67c)August 14, 2025 | msn.comCAMP4 Reports Second Quarter 2025 Financial Results and Corporate HighlightsAugust 14, 2025 | globenewswire.comCAMP4 Therapeutics Corporation Common Stock (CAMP)July 14, 2025 | nasdaq.comCan Camp4 Therapeutics (NASDAQ:CAMP) Afford To Invest In Growth?June 28, 2025 | finance.yahoo.comUrea Cycle Disorders Market to Register Sustainable Growth During the Study Period (2020–2034) | DelveInsightJune 20, 2025 | finance.yahoo.comWedbush Initiates Coverage of Camp4 Therapeutics (CAMP) with Outperform RecommendationMay 27, 2025 | msn.comCAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual MeetingMay 16, 2025 | globenewswire.comCAMP4 Reports First Quarter 2025 Financial Results and Corporate HighlightsMay 13, 2025 | globenewswire.comCAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual MeetingApril 28, 2025 | globenewswire.comUPDATE - CalAmp Announces Headquarters Relocation to Carlsbad, CA to Streamline Operations and Strengthen Technical HubMarch 28, 2025 | markets.businessinsider.comCAMP4 Reports Full Year 2024 Financial Results and Provides Corporate UpdateMarch 27, 2025 | globenewswire.comCAMP4 Appoints Multiple Industry Veterans to its Board of DirectorsMarch 18, 2025 | globenewswire.comCORRECTION - CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025March 13, 2025 | globenewswire.comCalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025March 13, 2025 | globenewswire.comCalAmp Welcomes Thomas Polan as Product Director for Student Safety Business UnitMarch 1, 2025 | finance.yahoo.comCAMP4 to Participate in Upcoming Investor ConferencesFebruary 6, 2025 | globenewswire.comCAMP4 Provides Corporate Updates and Highlights Key Upcoming MilestonesJanuary 7, 2025 | globenewswire.comCAMP4 to Participate in the Piper Sandler 36th Annual Healthcare ConferenceDecember 2, 2024 | globenewswire.comCAMP4 Reports Third Quarter 2024 Financial ResultsNovember 21, 2024 | globenewswire.comWilliam Blair Initiates Coverage of Camp4 Therapeutics (CAMP) with Outperform RecommendationNovember 7, 2024 | msn.comCAMP4 Analyst Highlights Rare Disease Platform PotentialNovember 5, 2024 | benzinga.comCamp4 Therapeutics initiated with an Outperform at LeerinkNovember 5, 2024 | markets.businessinsider.comCamp4 Therapeutics initiated with an Overweight at Piper SandlerNovember 5, 2024 | markets.businessinsider.comCAMP4 Announces Pricing of Initial Public OfferingOctober 10, 2024 | globenewswire.comCalAmp Industrial IoT Gateway Named an OEM Off-Highway 2024 Top New Product Award RecipientSeptember 24, 2024 | globenewswire.comCampina Ice Cream Industry Tbk PT (CAMP)August 30, 2024 | investing.comCalAmp Welcomes Thomas Ayers as General Manager of Edge Device BusinessAugust 29, 2024 | globenewswire.comCalAmp Launches Inventory Manager for Seamless Device DeploymentsAugust 6, 2024 | globenewswire.comLynrock Lake Takes CalAmp PrivateAugust 1, 2024 | globenewswire.comCalAmp Announces Appointment of Paul Washicko as Senior Vice President of Product ManagementJuly 9, 2024 | globenewswire.comCalAmp Announces General Availability of HMU3640LB Industrial GatewayJune 20, 2024 | globenewswire.comCalAmp Reaches Comprehensive Agreement to Significantly Reduce Debt, Go Private, and Strengthen Financial Flexibility to Support Innovation Through a Consensual Financial RestructuringJune 3, 2024 | globenewswire.comCalAmp Enhances School Bus Solutions Suite with Dispatch MonitorMay 1, 2024 | globenewswire.comCalAmp Corp. (CAMP)May 1, 2024 | finance.yahoo.comTop 3 Tech Stocks That Could Lead To Your Biggest Gains In March - CalAmp (NASDAQ:CAMP), Luna Innovations (NASDAQ:LUNA)March 21, 2024 | benzinga.comCalAmp Corp.: CalAmp Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 28, 2024 | finanznachrichten.deCalAmp Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 28, 2024 | finance.yahoo.comCalAmp Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 27, 2024 | globenewswire.comTop 3 Tech Stocks Which Could Rescue Your Portfolio This Month - Digital Turbine (NASDAQ:APPS), CalAmp (NASDAQ:CAMP)February 27, 2024 | benzinga.comCalAmp (CAMP) Price Target Increased by 2200.00% to 25.51February 24, 2024 | msn.comCalAmp Stock (NASDAQ:CAMP), Quotes and News SummaryFebruary 23, 2024 | benzinga.comCAMP Feb 2024 2.500 putFebruary 14, 2024 | finance.yahoo.comABUS, PI and CAMP are among after hour moversFebruary 8, 2024 | seekingalpha.comCAMP4 Therapeutics (Nasdaq:CAMP) HeadlineTrading was temporarily halted for "CAMP" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 09:02 AM. February 2, 2024 | marketbeat.comCAMP4 Therapeutics (Nasdaq:CAMP) HeadlineTrading was temporarily halted for "CAMP" at 07:02 PM with a stated reason of "News pending."...February 2, 2024 | marketbeat.comCalamp Stockholders Approve Reverse Split and Adjournment ProposalsJanuary 27, 2024 | msn.comCalAmp Corp.: CalAmp Reports Third Quarter Fiscal Year 2024 Financial ResultsJanuary 10, 2024 | finanznachrichten.deCalAmp Corp. (NASDAQ:CAMP) Q3 2024 Earnings Call TranscriptJanuary 10, 2024 | finance.yahoo.comCAMP Stock Earnings: CalAmp Misses EPS, Misses Revenue for Q3 2024January 9, 2024 | investorplace.com Get CAMP4 Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CAMP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CAMP Media Mentions By Week CAMP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CAMP News Sentiment▼0.001.03▲Average Medical News Sentiment CAMP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CAMP Articles This Week▼20▲CAMP Articles Average Week Get the Latest News and Ratings for CAMP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CAMP4 Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies KVHI News Today CMTL News Today AWRE News Today CSCO News Today QCOM News Today PANW News Today MSI News Today FFIV News Today CIEN News Today SATS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CAMP) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CAMP4 Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CAMP4 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access